Outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis-Reference-Cited by-同舟云学术

Outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis

Published:2020-07-24 Issue:10 Volume:34 Page:
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Griffin Jan M.¹^ORCID,Chiu Leonard¹,Axsom Kelly M.¹,Bijou Rachel¹,Clerkin Kevin J.¹^ORCID,Colombo Paolo¹,Cuomo Margaret O.¹,De Los Santos Jeffeny¹,Fried Justin A.¹,Goldsmith Jeff²,Habal Marlena¹^ORCID,Haythe Jennifer¹,Helmke Stephen¹,Horn Evelyn M.¹³,Latif Farhana¹,Hi Lee Sun¹,Lin Edward F.¹,Naka Yoshifumi⁴,Raikhelkar Jayant¹^ORCID,Restaino Susan¹,Sayer Gabriel T.¹,Takayama Hiroo⁴,Takeda Koji⁴,Teruya Sergio¹,Topkara Veli¹,Tsai Emily J.¹,Uriel Nir¹,Yuzefpolskaya Melana¹,Farr Maryjane A.¹,Maurer Mathew S.¹

Affiliation:

1. Center for Advanced Cardiac Care Division of Cardiology Columbia College of Physicians & Surgeons New York NY USA

2. Biostatistics Columbia University New York NY USA

3. Division of Cardiology Department of Medicine Weill‐Cornell Medical School New York NY USA

4. Division of Cardiothoracic Surgery Department of Surgery Columbia College of Physicians & Surgeons New York NY USA

Funder

Pfizer

National Heart, Lung, and Blood Institute

National Institute on Aging

Publisher

Wiley

Subject